![]() |
|
|
Vol. 282, Issue 3, 1198-1205, 1997
Intestinal Disease Research Program, Department of Medicine and
Honors Biology and Pharmacology Program, McMaster University, Hamilton,
Ontario, Canada
The isoprostanes, which differ from prostaglandins by the
cis orientation of their side chains, are believed to exert
their biological effects on either a prostanoid TP receptor or a
"unique" isoprostane receptor. Preliminary experiments suggested
that canine colonic epithelium possessed no prostanoid TP receptor
activity, in contrast to the muscularis mucosae, which responds well to the selective prostanoid TP receptor agonist U46619. To define the
receptors involved, the in vitro responses of the epithelium and muscularis mucosae from the canine proximal colon to both 8-iso-PGE2 and
8-iso-PGF2
were compared. The epithelium
responded to 8-iso-PGE2 but not to
8-iso-PGF2
. Under basal conditions, 8-iso-PGE2 produced concentration-dependent
increases in short circuit current (pEC50 = 6.4 ± 0.1) that were not antagonized by the selective prostanoid
TP receptor antagonist SQ29548 (10
6 M).
Cross-desensitization experiments suggested that the stimulant effects
involved a prostanoid EP receptor. Desensitization of the epithelium to
PGE2 resulted in unexpected decreases in short circuit current in response to 8-iso-PGE2
(10
6 M). This effect was mimicked by the
selective prostanoid TP receptor agonist U46619
(10
5 M), and antagonized by three structurally
different prostanoid TP receptor antagonists: L670596
(10
6 M), SQ29548 (10
6
M) and GR32191 (10
6 M).
8-Iso-PGE2,
8-iso-PGF2
and U46619 caused
concentration-dependent increases in the force of contraction of the
muscularis mucosae strips. These responses were antagonized by
selective prostanoid TP receptor antagonists, arguing for the
involvement of prostanoid TP receptors. Thus, the effects of
isoprostanes on the canine colon involve both prostanoid TP and EP
receptors.
This article has been cited by other articles:
![]() |
L. J. Janssen Isoprostanes and Lung Vascular Pathology Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 383 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Paredes, T. Tazzeo, and L. J. Janssen E-Ring Isoprostane Augments Cholinergic Neurotransmission in Bovine Trachealis via FP Prostanoid Receptors Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 739 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Ansari, A. Nadeem, S. L. Tilley, and S. J. Mustafa Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3448 - H3455. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cong, Z.-L. Xiao, P. Biancani, and J. Behar Prostaglandins mediate tonic contraction of the guinea pig and human gallbladder Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G409 - G418. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3395 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Cowley Isoprostane-Mediated Secretion from Human Airway Epithelial Cells Mol. Pharmacol., August 1, 2003; 64(2): 298 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catalli, D. Zhang, and L. J. Janssen Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1151 - L1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Jankov, R. Belcastro, E. Ovcina, J. Lee, H. Massaeli, S. J. Lye, and A. K. Tanswell Thromboxane A2 Receptors Mediate Pulmonary Hypertension in 60% Oxygen-exposed Newborn Rats by a Cyclooxygenase-independent Mechanism Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 208 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Janssen and T. Tazzeo Involvement of TP and EP3 Receptors in Vasoconstrictor Responses to Isoprostanes in Pulmonary Vasculature J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1060 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tintut, F. Parhami, A. Tsingotjidou, S. Tetradis, M. Territo, and L. L. Demer 8-Isoprostaglandin E2 Enhances Receptor-activated NFkappa B Ligand (RANKL)-dependent Osteoclastic Potential of Marrow Hematopoietic Precursors via the cAMP Pathway J. Biol. Chem., April 12, 2002; 277(16): 14221 - 14226. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Unmack, P. K. Rangachari, and E. Skadhauge Effects of Isoprostanes and Prostanoids on Porcine Small Intestine J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 434 - 441. [Abstract] [Full Text] |
||||
![]() |
L. J. Janssen, M. Premji, S. Netherton, A. Catalli, G. Cox, S. Keshavjee, and D. J. Crankshaw Excitatory and Inhibitory Actions of Isoprostanes in Human and Canine Airway Smooth Muscle J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 506 - 511. [Abstract] [Full Text] |
||||
![]() |
A. R. Evans, H. Junger, M. D. Southall, G. D. Nicol, L. S. Sorkin, J. T. Broome, T. W. Bailey, and M. R. Vasko Isoprostanes, Novel Eicosanoids That Produce Nociception and Sensitize Rat Sensory Neurons J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 912 - 920. [Abstract] [Full Text] |
||||
![]() |
D. M. McKay, J. Lu, S. Jedrzkiewicz, W. Ho, and K. A. Sharkey Nitric Oxide Participates in the Recovery of Normal Jejunal Epithelial Ion Transport Following Exposure to the Superantigen, Staphylococcus aureus Enterotoxin B J. Immunol., October 15, 1999; 163(8): 4519 - 4526. [Abstract] [Full Text] [PDF] |
||||